Steve Hoffman
Algemeen Directeur bij Tyme, Inc.
Actieve functies van Steve Hoffman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Directeur/Bestuurslid | 01-07-2013 | - |
| Algemeen Directeur | 01-07-2013 | - |
Loopbaan van Steve Hoffman
Eerdere bekende functies van Steve Hoffman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Algemeen Directeur | 01-01-2014 | 24-11-2020 |
| Voorzitter | 01-01-2014 | 21-03-2022 | |
| Hoofd Techniek/Wetenschap/O&O | 05-03-2015 | 21-03-2022 | |
| Oprichter | 22-11-2011 | 21-03-2022 | |
| Luminant Biosciences LLC | Algemeen Directeur | 01-03-2015 | 01-10-2020 |
| Hoofd Techniek/Wetenschap/O&O | 01-09-2011 | 01-10-2020 | |
| Oprichter | 01-09-2011 | 01-10-2020 | |
Mikronite Technologies Group, Inc.
 Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-01-1993 | 01-01-2007 |
| Oprichter | 01-01-1993 | 01-01-2007 |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Executive Officer | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
Sectoraal
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Mikronite Technologies Group, Inc.
Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Producer Manufacturing |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
| Luminant Biosciences LLC |
- Beurs
- Insiders
- Steve Hoffman
- Ervaring
